The IPO Buzz: Virax Biolabs’ Stock Jumps 300 Percent in NASDAQ Debut
Virax Biolabs Group Limited (VRAX) shares shot up to $20.01 – a jump of 300.2 percent from their IPO price – on Thursday (July 21, 2022) in late morning trading on the NASDAQ. The COVID-19 diagnostic test and PPE company priced its IPO on Wednesday night (July 20, 2022) at $5.00 and sold 1.35 million shares, […]
July 21, 2022 Read More